Further extensive cohort studies are needed to confirm the roles of adipokines in diabetes-related cognitive impairment pathogenesis and investigate the potential of adiponectin and leptin as diagnostic markers of cognitive dysfunction. This evidence concerns the gene ADIPOQ and Cognitive impairment.